Carregant...
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
SIMPLE SUMMARY: The prognosis and treatment of metastatic melanoma have changed substantially since the advent of target therapy and immune checkpoint inhibitors. Thus, strategies must be developed to identify responder patients, reduce toxicities, and investigate target and immune based therapy ide...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699774/ https://ncbi.nlm.nih.gov/pubmed/33233603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113456 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|